A citation-based method for searching scientific literature

Anne Brédart, Jean-Luc Kop, Antoine De Pauw, Olivier Caron, Anne Fajac, Catherine Noguès, Dominique Stoppa-Lyonnet, Sylvie Dolbeault. Breast 2017
Times Cited: 10







List of co-cited articles
39 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Joël Vos, Encarna Gómez-García, Jan C Oosterwijk, Fred H Menko, Reinoud D Stoel, Christi J van Asperen, Anna M Jansen, Anne M Stiggelbout, Aad Tibben. Psychooncology 2012
50
40

The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.
Joël Vos, Wilma Otten, Christi van Asperen, Anna Jansen, Fred Menko, Aad Tibben. Psychooncology 2008
82
30

Family Communication, Risk Perception and Cancer Knowledge of Young Adults from BRCA1/2 Families: a Systematic Review.
Alison L Young, Phyllis N Butow, Janine Vetsch, Veronica F Quinn, Andrea F Patenaude, Katherine M Tucker, Claire E Wakefield. J Genet Couns 2017
23
30

Communication about genetic testing with breast and ovarian cancer patients: a scoping review.
Chris Jacobs, Christine Patch, Susan Michie. Eur J Hum Genet 2019
18
30


The Genetic Counseling Video Project (GCVP): models of practice.
D Roter, L Ellington, L Hamby Erby, S Larson, W Dudley. Am J Med Genet C Semin Med Genet 2006
78
20

Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
61
20


Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
Sandra van Dijk, Daniëlle R M Timmermans, Hanne Meijers-Heijboer, Aad Tibben, Christi J van Asperen, Wilma Otten. J Clin Oncol 2006
60
20

Understanding of BRCA VUS genetic results by breast cancer specialists.
B K Eccles, E Copson, T Maishman, J E Abraham, D M Eccles. BMC Cancer 2015
54
20

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
Suzanne C O'Neill, Christine Rini, Rachel E Goldsmith, Heiddis Valdimarsdottir, Lawrence H Cohen, Marc D Schwartz. Psychooncology 2009
71
20

Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
J O Culver, C D Brinkerhoff, J Clague, K Yang, K E Singh, S R Sand, J N Weitzel. Clin Genet 2013
57
20

Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
Ilana Solomon, Elizabeth Harrington, Gillian Hooker, Lori Erby, Jennifer Axilbund, Heather Hampel, Kara Semotiuk, Amie Blanco, William M P Klein, Francis Giardiello,[...]. J Genet Couns 2017
30
20

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
20

A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes.
J M Eggington, K R Bowles, K Moyes, S Manley, L Esterling, S Sizemore, E Rosenthal, A Theisen, J Saam, C Arnell,[...]. Clin Genet 2014
118
20


Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
20

Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study.
Mirjam Tonheim Augestad, Hildegunn Høberg-Vetti, Cathrine Bjorvatn, Ragnhild Johanne Tveit Sekse. J Genet Couns 2017
14
20

Rapid genetic counseling and testing in newly diagnosed breast cancer: Patients' and health professionals' attitudes, experiences, and evaluation of effects on treatment decision making.
Marijke R Wevers, Neil K Aaronson, Eveline M A Bleiker, Daniela E E Hahn, Titia Brouwer, Thijs van Dalen, Evert B Theunissen, Bart van Ooijen, Marnix A de Roos, Paul J Borgstein,[...]. J Surg Oncol 2017
9
22

High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling.
Aisha S Sie, Liesbeth Spruijt, Wendy A G van Zelst-Stams, Arjen R Mensenkamp, Marjolijn J L Ligtenberg, Han G Brunner, Judith B Prins, Nicoline Hoogerbrugge. J Genet Couns 2016
21
20

Patients' memory for medical information.
Roy P C Kessels. J R Soc Med 2003
659
20


An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling.
K A Metcalfe, A Liede, E Hoodfar, A Scott, W D Foulkes, S A Narod. J Med Genet 2000
72
20

Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes.
E A Lobb, P N Butow, A Barratt, B Meiser, C Gaff, M A Young, E Haan, G Suthers, M Gattas, K Tucker. Br J Cancer 2004
97
20


Clinician characteristics, communication, and patient outcome in oncology: a systematic review.
A M M De Vries, Y de Roten, C Meystre, J Passchier, J-N Despland, F Stiefel. Psychooncology 2014
46
20

Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial.
Veronica F Quinn, Bettina Meiser, Judy Kirk, Kathy M Tucker, Kaaren J Watts, Belinda Rahman, Michelle Peate, Christobel Saunders, Elizabeth Geelhoed, Margaret Gleeson,[...]. Genet Med 2017
19
20

Variants of uncertain clinical significance as a result of BRCA1/2 testing: impact of an ambiguous breast cancer risk message.
Sandra van Dijk, Christi J van Asperen, Catharina E Jacobi, Geraldine R Vink, Aad Tibben, Martijn H Breuning, Wilma Otten. Genet Test 2004
32
20

Accuracy of recall of information about a cancer-predisposing BRCA1/2 gene mutation among patients and relatives.
Chris Jacobs, Caroline Dancyger, Jonathan A Smith, Susan Michie. Eur J Hum Genet 2015
18
20

Assessment of the content and process of genetic counseling: a critical review of empirical studies.
Bettina Meiser, Jennifer Irle, Elizabeth Lobb, Kristine Barlow-Stewart. J Genet Couns 2008
97
20

Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing.
Julien Mancini, Catherine Noguès, Claude Adenis, Pascaline Berthet, Valerie Bonadona, Agnès Chompret, Isabelle Coupier, François Eisinger, Jean-Pierre Fricker, Marion Gauthier-Villars,[...]. Eur J Cancer 2006
32
20

Effective communication skills are the key to good cancer care.
L Fallowfield, V Jenkins. Eur J Cancer 1999
307
20




"When information is not enough": A model for understanding BRCA-positive previvors' information needs regarding hereditary breast and ovarian cancer risk.
Marleah Dean, Courtney L Scherr, Meredith Clements, Rachel Koruo, Jennifer Martinez, Amy Ross. Patient Educ Couns 2017
20
20

Family communication about positive BRCA1 and BRCA2 genetic test results.
Bobbi McGivern, Jessica Everett, Geoffrey G Yager, Robert C Baumiller, Amanda Hafertepen, Howard M Saal. Genet Med 2004
89
20

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
560
20

Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort.
Kerstin Rhiem, Hans-Joachim Bücker-Nott, Martin Hellmich, Holger Fischer, Beyhan Ataseven, Christine Dittmer-Grabowski, Kunibert Latos, Volker Pelzer, Manuela Seifert, Andrea Schmidt,[...]. Breast J 2019
11
20

Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning?
Maya Ghoussaini, Paul D P Pharoah, Douglas F Easton. Am J Pathol 2013
52
10

Breast cancer after bilateral risk-reducing mastectomy.
A-B Skytte, D Crüger, M Gerster, A-V Laenkholm, C Lang, K Brøndum-Nielsen, M K Andersen, L Sunde, S Kølvraa, A-M Gerdes. Clin Genet 2011
32
10

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
483
10

High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
Virginie Bubien, Françoise Bonnet, Veronique Brouste, Stéphanie Hoppe, Emmanuelle Barouk-Simonet, Albert David, Patrick Edery, Armand Bottani, Valérie Layet, Olivier Caron,[...]. J Med Genet 2013
157
10


Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
498
10

Risk of breast cancer in male BRCA2 carriers.
D G R Evans, I Susnerwala, J Dawson, E Woodward, E R Maher, F Lalloo. J Med Genet 2010
59
10

Counselling framework for moderate-penetrance cancer-susceptibility mutations.
Nadine Tung, Susan M Domchek, Zsofia Stadler, Katherine L Nathanson, Fergus Couch, Judy E Garber, Kenneth Offit, Mark E Robson. Nat Rev Clin Oncol 2016
164
10

Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
Christiane Kuhl, Stefanie Weigel, Simone Schrading, Birke Arand, Heribert Bieling, Roy König, Bernd Tombach, Claudia Leutner, Andrea Rieber-Brambs, Dennis Nordhoff,[...]. J Clin Oncol 2010
267
10

Peutz-Jeghers syndrome: a systematic review and recommendations for management.
A D Beggs, A R Latchford, H F A Vasen, G Moslein, A Alonso, S Aretz, L Bertario, I Blanco, S Bülow, J Burn,[...]. Gut 2010
341
10

The Global Burden of Cancer 2013.
Christina Fitzmaurice, Daniel Dicker, Amanda Pain, Hannah Hamavid, Maziar Moradi-Lakeh, Michael F MacIntyre, Christine Allen, Gillian Hansen, Rachel Woodbrook, Charles Wolfe,[...]. JAMA Oncol 2015
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.